Skip to main content

People in the News: Jun 16, 2011

Premium

Alnylam Pharmaceuticals has appointed Akshay Vaishnaw to the newly created position of chief medical officer.

Vaishnaw was previously senior vice president of clinical research at Alnylam. Before that, he was senior director of translational medicine at Biogen Idec.


Mirna Therapeutics has appointed Art Krieg as a scientific advisor.

Krieg is currently an entrepreneur in residence at venture capital firm Atlas Ventures. Before this, he served as CSO of Pfizer's oligonucleotide therapeutics unit, which was recently shut down as part of a corporate restructuring.

He was also the CSO and co-founder of Coley Pharmaceuticals, which was acquired by Pfizer in 2008.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.